Clinical Trial Update: A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating allogeneic human umbilical cord mesenchymal stem cells with Liberation Therapy for relapsing-remitting multiple sclerosis ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Allogeneic Umbilical Cord Mesenchymal Stem Cells (UC-MSC) (umbilical cord mesenchymal stem cells)
• Liberation Therapy

Snippet

Sponsor: Genesis Limited | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 1, Phase 2 | Status: TERMINATED